Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
Cocrystal Pharma (Nasdaq: COCP) will present at Noble Capital Markets’ 21st Emerging Growth Equity Conference on Wednesday, December 3, 2025 at 10:00 AM ET.
Rhea-AI Summary
Cocrystal Pharma (Nasdaq: COCP) will present at Noble Capital Markets’ 21st Emerging Growth Equity Conference on Wednesday, December 3, 2025 at 10:00 AM ET. James Martin, CFO and co-CEO, will give a company overview and a clinical progress update at the Executive Education Complex of Florida Atlantic University in Boca Raton, Florida.
A video webcast of the presentation will be posted on December 4, 2025 on the company website and will be archived for 90 days. Interested investors can attend the conference at a discounted rate using code COCPNOBLECON.
Positive
- None.
Negative
- None.
Details
News Market Reaction – COCP
On Dec 1, the day this news came out, COCP closed 2.83% below the previous close.
Data tracked by StockTitan Argus for the Dec 1 session.
Key Figures
- Conference date/time
- December 3, 2025 at 10:00 am ET
- Scheduled NobleCon 21 company presentation
- Webcast availability date
- December 4, 2025
- Date webcast becomes available on company website
- Webcast archive duration
- 90 days
- Length of time conference presentation remains accessible online
Historical Context
-
Announcement of NobleCon 21 company overview and clinical progress presentation.
-
Q3 2025 results with IND clearance, NIH award and recent financings.
-
Insider-led private placement with units and warrants for clinical funding.
-
Non-dilutive NIH/NIAID SBIR Phase I funding for influenza program.
-
Noble Capital virtual equity conference presentation with Q&A and meetings.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a Company overview and clinical progress update at NobleCon 21 – Noble Capital Markets 21st Emerging Growth Equity Conference on Wednesday, December 3, 2025 at 10:00 am Eastern time. The conference is being held at the Executive Education Complex of Florida Atlantic University in Boca Raton, Florida.
Interested investors and guests of Cocrystal Pharma are welcome to attend the conference at a discounted rate. Please register here using the discount code COCPNOBLECON.
A video webcast of the Cocrystal presentation will be available on December 4, one day after the live event, on the Company's website and archived for 90 days.
About Noble Capital Markets, Inc.
Noble Capital Markets is a research-driven investment bank that has supported small and microcap companies since 1984. As a FINRA and SEC licensed broker dealer, Noble provides institutional-quality equity research, merchant and investment banking, and order execution services. In 2018, Noble launched Channelchek—an investor community dedicated exclusively to public small and micro-cap companies and their industries. Channelchek is the first service to offer investors free institutional-quality research without a subscription.
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company that addresses significant unmet needs by developing innovative antiviral treatments for challenging diseases including influenza, viral gastroenteritis, COVID, and hepatitis. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs.
Contact:
Alliance Advisors IR
Jody Cain
310-691-7100
jcain@allianceadvisors.com
# # #
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.